Sanofi Elitek For Uric Acid Management Will Launch By Mid-August
Executive Summary
Sanofi-Synthelabo plans to launch Elitek for the management of uric acid in pediatric oncology patients by mid-August
You may also be interested in...
Ilex Resembles Recent Biotech Acquisition Targets As Campath Nears Market
Ilex Oncology appears to fit the profile of recently acquired companies within the biotechnology industry.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials